ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Warszawa, Mazowieckie, POL:

A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer

The aim of this study is to compare the safety and efficacy of SHR3680 with bicalutamide in the treatment of patients with hormone sensitive prostate...

Active, not recruiting
Hormone-Dependent Prostate Cancer
Prostate Cancer
Drug: Bicalutamide
Drug: SHR3680

Phase 3

Hengrui Medicine
Hengrui Medicine

Wesoła, Weigla, Poland and 66 other locations

The objectives of this study are to evaluate the feasibility and safety of \[99mTc\]Tc-PSMA-T4 in the diagnosis and treatment planning of prostate...

Enrolling
Prostate Cancer
Radiation: [99mTc]Tc-PSMA-T4
NCBJ Polatom: Narodowe Centrum Badań Jądrowych Polatom

Warszawa, Lelechowska 5, Poland and 2 other locations

patients with progressive metastatic castration-resistant prostate cancer (mCRPC).The following assessment of prostate cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Prostate Cancer Metastatic
Drug: Enzalutamide
Drug: HC-1119

Phase 3

Hinova Pharmaceuticals

Warszawa, Poland and 57 other locations

therapy in participants with metastatic castration resistant prostate cancer (mCRPC). There will be ten cohorts in this study: Coho...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Drug: Enzalutamide 160 mg
Drug: Olaparib 400 mg

Phase 1, Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Warsaw, Poland and 29 other locations

plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the doce...

Enrolling
Prostate Cancer
Drug: docetaxel
Other: placebo

Phase 3

AstraZeneca
AstraZeneca

Warszawa, Poland and 250 other locations

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Apalutamide
Drug: Placebo

Phase 3

Aragon Pharmaceuticals

Warszawa, Poland and 388 other locations

to radiographic progression-free survival (rPFS) per 1) Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 for soft tissue and/or Prostate...

Active, not recruiting
Hormone-Sensitive Prostate Cancer
Drug: Capivasertib
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Warszawa, Poland and 322 other locations

A Phase 1 Dose Escalation and Expanded Cohort Study Of PF-06821497 (Mevrometostat) in Adult Patients With Relapsed/Refractory Small Cell Lung Cancer...

Enrolling
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Small Cell Lung Cancer (SCLC)
Drug: Enzalutamide
Drug: Mervometostat (PF-06821497)

Phase 1

Pfizer
Pfizer

Warszawa, Poland and 100 other locations

is to evaluate the effectiveness, safety and tolerability of nivolumab followed by ipilimumab, in subjects with metastatic castration resistant prostate...

Active, not recruiting
Prostate Cancer
Biological: Nivolumab
Biological: Ipilimumab

Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Warszawa, Poland and 58 other locations

The purpose of this study was to evaluate the efficacy of enzalutamide plus androgen deprivation therapy (ADT) as measured by radiographic progressio...

Active, not recruiting
Metastatic Hormone Sensitive Prostate Cancer
Drug: Enzalutamide
Drug: Placebo

Phase 3

Astellas
Astellas

Warszawa, Mazowieckie, Poland and 202 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems